Abstract
Despite chemotherapy and intended curative surgery, approximately 50% of patients with gastric cancer develop recurrence and eventually die of metastatic disease. The detection of circulating tumour cells (CTC) in peripheral blood is a promising prognostic and predictive marker. The most typically applied approaches to the detection of CTC are RT-PCR and immunological assays. Measurement of CTC in gastric cancer seems useful for predicting prognosis and monitoring response of chemotherapy. There is still no gold standard for CTC-detection in gastric cancer patients and larger studies are needed.
Bidragets oversatte titel | Circulating tumour cells is a promising prognostic and predictive marker of gastric cancer. |
---|---|
Originalsprog | Dansk |
Artikelnummer | V01130083 |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 176 |
Udgave nummer | 16 |
Sider (fra-til) | 1490-1493 |
Antal sider | 4 |
ISSN | 0041-5782 |
Status | Udgivet - 4 aug. 2014 |